Impact of donor extracellular vesicle release on recipient cell ‘cross‐dressing’ following clinical liver and kidney transplantation

dc.contributor.authorMastoridis, Sotiris
dc.contributor.authorLondoño, María Carlota
dc.contributor.authorKurt, Ada
dc.contributor.authorKodela, Elisavet
dc.contributor.authorCrespo, Elena
dc.contributor.authorMason, John
dc.contributor.authorBestard Matamoros, Oriol
dc.contributor.authorMartínez Llordella, Marc
dc.contributor.authorSánchez Fueyo, Alberto
dc.date.accessioned2021-02-22T09:24:27Z
dc.date.available2021-02-22T09:24:27Z
dc.date.issued2020-07-05
dc.date.updated2021-02-18T14:28:42Z
dc.description.abstractIn several murine models of transplantation, the "cross-dressing" of recipient antigen presenting cells (APCs) with intact donor major histocompatibility complex (MHC) derived from allograft-released small extracellular vesicles (sEVs) has been recently described as a key mechanism in eliciting and sustaining alloimmune responses. Investigation of these processes in clinical organ transplantation has, however, been hampered by the lack of sensitivity of conventional instruments and assays. We have employed advanced imaging flow cytometry (iFCM) to explore the kinetics of allograft sEV release and the extent to which donor sEVs might induce cross-dressing following liver and kidney transplantation. We report for the first time that recipient APC cross-dressing can be transiently detected in the circulation shortly after liver, but not kidney, transplantation in association with the release of HLA-bearing allograft-derived sEVs. In liver transplant recipients the majority of circulating cells exhibiting donor HLA are indeed cross-dressed cells and not passenger leukocytes. In keeping with experimental animal data, the downstream functional consequences of the transfer of circulating sEVs harvested from human transplant recipients varies depending on the type of transplant and time posttransplant. sEVs released shortly after liver, but not kidney, transplantation exhibit immunoinhibitory effects that could influence liver allograft immunogenicity.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid32515541
dc.identifier.urihttps://hdl.handle.net/2445/174129
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1111/ajt.16123
dc.relation.ispartofAmerican Journal of Transplantation, 2020
dc.relation.urihttps://doi.org/10.1111/ajt.16123
dc.rightscc by (c) Mastoridis, Sotiris et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationTrasplantament de ronyó
dc.subject.classificationTrasplantament hepàtic
dc.subject.classificationImmunologia de la trasplantació
dc.subject.otherKidney transplantation
dc.subject.otherHepatic transplantation
dc.subject.otherTransplantation immunology
dc.titleImpact of donor extracellular vesicle release on recipient cell ‘cross‐dressing’ following clinical liver and kidney transplantation
dc.typeinfo:eu-repo/semantics/article

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
ajt.16123.pdf
Mida:
1.1 MB
Format:
Adobe Portable Document Format